Hey Rick:
Yes, things have been slow around here. Thanks to Robin and Paul we are still getting some information about PRLN.
I think all of us have been dissapointed in the lack of communication by PRLN. I think we thought we would hear news in November regarding the conference, and instead, we got nothing. Remember the old days when we got GOOD press releases at least once a month?
But Paul and Robin have some good analysis to suggest that paracelsian is holding back. When this study is released, I am hoping to see some major interest by individual stockholders in this stock.
I am not buying anymore. Until I hear something, I am in a hold position. I have been tempted to sell, but that was emotion, not rationality.
I agree with you about the knowledge about AndroCar among physicians. However, there are LOTS of experimental drugs out there. In fact, I have a friend who is on several different databases for such drugs (apparently, they are run by NIH). From what I know, I think doctors don't always think real highly of experimental drugs. They often get downcasted about such drugs, as "this is your last hope." I think it takes holistic (sp) doctors to consider drugs like AndroCar. |
